IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Delphi Management Partners VIII, L.L.C.

Q2 2021 Holdings

Filed 2021-08-12 | 4 holdings | $126.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Tandem Diabetes, Inc.(TNDM)Common Stock875372203$97.4K1,000,00076.9%
Karyopharm Therapeutics, Inc.(KPTIEUR)Common Stock48576U106$23.4K2,263,00618.4%
Calithera Biosciences, Inc.(CALAEUR)Common Stock13089P101$5.1K2,426,7024.0%
Mereo BioPharma Group PLC(MREO)ADS589492107$814256,7340.6%